XK
Xact Kapitalforvaltning Portfolio holdings
AUM
$4.7B
1-Year Return
0.05%
This Quarter Return
+5.68%
1 Year Return
-0.05%
3 Year Return
+34.2%
5 Year Return
–
10 Year Return
–
AUM
$2.82B
AUM Growth
–
Cap. Flow
+$2.82B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
18.31%
Holding
628
New
628
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Apple
AAPL
|
$114M |
| 2 |
Microsoft
MSFT
|
$66M |
| 3 |
Johnson & Johnson
JNJ
|
$52.6M |
| 4 |
Amazon
AMZN
|
$51.8M |
| 5 |
Meta Platforms (Facebook)
META
|
$47.2M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 16.8% |
| 2 | Financials | 16.26% |
| 3 | Healthcare | 16.04% |
| 4 | Consumer Discretionary | 11.34% |
| 5 | Communication Services | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Walt Disney
DIS
$214B
| $23.5M | 0.83% |
+253,482
| New | +$23.5M |
|
27
Citigroup
C
$179B
| $21.7M | 0.77% |
+458,810
| New | +$21.7M |
|
28
UnitedHealth
UNH
$281B
| $21.6M | 0.77% |
+154,597
| New | +$21.6M |
|
29
IBM
IBM
$230B
| $20.8M | 0.74% |
+136,813
| New | +$20.8M |
|
30
Oracle
ORCL
$626B
| $20M | 0.71% |
+509,994
| New | +$20M |
|
31
Amgen
AMGN
$151B
| $19.6M | 0.7% |
+117,775
| New | +$19.6M |
|
32
Alibaba
BABA
$312B
| $19.3M | 0.68% |
+182,337
| New | +$19.3M |
|
33
Gilead Sciences
GILD
$140B
| $18.2M | 0.65% |
+230,127
| New | +$18.2M |
|
34
Medtronic
MDT
$119B
| $17.8M | 0.63% |
+205,662
| New | +$17.8M |
|
35
GE Aerospace
GE
$299B
| $17.7M | 0.63% |
+124,907
| New | +$17.7M |
|
36
Mastercard
MA
$538B
| $16.2M | 0.58% |
+159,653
| New | +$16.2M |
|
|
CELG
37
DELISTED
Celgene Corp
CELG
| $15.5M | 0.55% |
+148,369
| New | +$15.5M |
|
38
Qualcomm
QCOM
$172B
| $15.1M | 0.54% |
+220,853
| New | +$15.1M |
|
39
AbbVie
ABBV
$376B
| $15.1M | 0.53% |
+238,622
| New | +$15.1M |
|
40
3M
MMM
$82.8B
| $14.9M | 0.53% |
+100,801
| New | +$14.9M |
|
41
CVS Health
CVS
$93.5B
| $14.8M | 0.52% |
+165,977
| New | +$14.8M |
|
|
AGN
42
DELISTED
Allergan plc
AGN
| $14M | 0.5% |
+60,695
| New | +$14M |
|
43
Bristol-Myers Squibb
BMY
$95B
| $13.5M | 0.48% |
+251,284
| New | +$13.5M |
|
44
Chevron
CVX
$318B
| $12.7M | 0.45% |
+123,184
| New | +$12.7M |
|
45
Eli Lilly
LLY
$666B
| $12.7M | 0.45% |
+157,645
| New | +$12.7M |
|
46
Broadcom
AVGO
$1.44T
| $12.4M | 0.44% |
+718,010
| New | +$12.4M |
|
47
Accenture
ACN
$158B
| $12.2M | 0.43% |
+100,068
| New | +$12.2M |
|
48
Thermo Fisher Scientific
TMO
$185B
| $12.1M | 0.43% |
+75,767
| New | +$12.1M |
|
49
Booking.com
BKNG
$181B
| $11.9M | 0.42% |
+8,118
| New | +$11.9M |
|
50
Starbucks
SBUX
$98.9B
| $11.6M | 0.41% |
+214,452
| New | +$11.6M |
|